Patents/Assignees

Apellis Pharmaceuticals, Inc.

8 patents in portfolio

US12528836utility2026
Dosing Regimens
0 cites
US12458695utility2025
Dosing Regimens and Related Compositions and Methods
0 cites
US12290566utility2025
Dosing Regimens and Related Compositions and Methods
0 cites
US12251395utility2025
RNAS for Complement Inhibition
0 cites
US11903994utility2024
Dosing Regimens
0 cites
US11844841utility2023
Dosing Regimens and Related Compositions and Methods
0 cites
US11712460utility2023
Methods of Treating Chronic Disorders with Complement Inhibitors
0 cites
US11661441utility2023
Cell-reactive, Long-acting, or Targeted Compstatin Analogs and Uses Thereof
0 cites